Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

94 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Protein kinase C-theta inhibitors: a novel therapy for inflammatory disorders.
Chand S, Mehta N, Bahia MS, Dixit A, Silakari O. Chand S, et al. Among authors: silakari o. Curr Pharm Des. 2012;18(30):4725-46. doi: 10.2174/138161212802651625. Curr Pharm Des. 2012. PMID: 22830352 Review.
Pharmacophore mapping of diverse classes of farnesyltransferase inhibitors.
Equbal T, Silakari O, Rambabu G, Ravikumar M. Equbal T, et al. Among authors: silakari o. Bioorg Med Chem Lett. 2007 Mar 15;17(6):1594-600. doi: 10.1016/j.bmcl.2006.12.087. Epub 2007 Jan 4. Bioorg Med Chem Lett. 2007. PMID: 17236767
Exploring three-dimensional quantitative structural activity relationship (3D-QSAR) analysis of SCH 66336 (Sarasar) analogues of farnesyltransferase inhibitors.
Equbal T, Silakari O, Ravikumar M. Equbal T, et al. Among authors: silakari o. Eur J Med Chem. 2008 Jan;43(1):204-9. doi: 10.1016/j.ejmech.2007.02.013. Epub 2007 Mar 2. Eur J Med Chem. 2008. PMID: 17442459
Three-dimensional quantitative structure-activity relationship modeling of gamma-secretase inhibitors using molecular field analysis.
Sammi T, Silakari O, Ravikumar M. Sammi T, et al. Among authors: silakari o. Chem Biol Drug Des. 2008 Feb;71(2):155-66. doi: 10.1111/j.1747-0285.2007.00622.x. Epub 2008 Jan 22. Chem Biol Drug Des. 2008. PMID: 18221306
Three-dimensional quantitative structure-activity relationship (3D-QSAR) studies of various benzodiazepine analogues of gamma-secretase inhibitors.
Sammi T, Silakari O, Ravikumar M. Sammi T, et al. Among authors: silakari o. J Mol Model. 2009 Apr;15(4):343-8. doi: 10.1007/s00894-008-0361-5. Epub 2008 Dec 6. J Mol Model. 2009. PMID: 19067000
Three dimensional pharmacophore modelling for c-Kit receptor tyrosine kinase inhibitors.
Kansal N, Silakari O, Ravikumar M. Kansal N, et al. Among authors: silakari o. Eur J Med Chem. 2010 Jan;45(1):393-404. doi: 10.1016/j.ejmech.2009.09.013. Epub 2009 Sep 30. Eur J Med Chem. 2010. PMID: 19892442
Anthranilate derivatives as TACE inhibitors: docking based CoMFA and CoMSIA analyses.
Bahia MS, Gunda SK, Gade SR, Mahmood S, Muttineni R, Silakari O. Bahia MS, et al. Among authors: silakari o. J Mol Model. 2011 Jan;17(1):9-19. doi: 10.1007/s00894-010-0695-7. Epub 2010 Mar 28. J Mol Model. 2011. PMID: 20349256
Tumor necrosis factor alpha converting enzyme: an encouraging target for various inflammatory disorders.
Bahia MS, Silakari O. Bahia MS, et al. Among authors: silakari o. Chem Biol Drug Des. 2010 May;75(5):415-43. doi: 10.1111/j.1747-0285.2010.00950.x. Chem Biol Drug Des. 2010. PMID: 20486929 Review.
A three-dimensional pharmacophore modelling of ITK inhibitors and virtual screening for novel inhibitors.
Bagga V, Silakari O, Ghorela VS, Bahia MS, Rambabu G, Sarma J. Bagga V, et al. Among authors: silakari o. SAR QSAR Environ Res. 2011 Mar;22(1-2):171-90. doi: 10.1080/1062936X.2010.510480. SAR QSAR Environ Res. 2011. PMID: 21391146
Inhibitors of interleukin-2 inducible T-cell kinase as potential therapeutic candidates for the treatment of various inflammatory disease conditions.
Kaur M, Bahia MS, Silakari O. Kaur M, et al. Among authors: silakari o. Eur J Pharm Sci. 2012 Oct 9;47(3):574-88. doi: 10.1016/j.ejps.2012.07.013. Epub 2012 Jul 20. Eur J Pharm Sci. 2012. PMID: 22820564 Review.
94 results
Jump to page
Feedback